Abivax SA (ABVX)
111.15
-2.39
(-2.10%)
USD |
NASDAQ |
Jan 30, 16:00
111.90
+0.75
(+0.67%)
After-Hours: 20:00
Abivax Market Cap : 8.719B for Jan. 30, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 928.27B |
| DBV Technologies SA | 591.29M |
| Inventiva SA | 898.50M |
| Cellectis SA | 380.23M |
| Innate Pharma SA | 171.48M |
Market Cap Related Metrics
| Price | 111.15 |